Prolactin has previously been found to be a blood-borne risk marker for breast cancer in postmenopausal women, particularly for estrogen receptor positive (ER+) and progesterone receptor positive (PR+) cancers [28]. The gene discussed is ESR1; the disease is breast cancer.